S8 Ep45: FDA Approval Insights: Omidubicel in Blood Cancers Requiring Transplant
Dr Horwitz discusses the FDA approval of omidubicel in patients with blood cancers, key efficacy and safety data from the pivotal phase 3 trial, and the benefits omidubicel provides beyond improved neutrophil engraftment.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.